- Home
- TRNS vs KROS Comparison
TRNS vs KROS Comparison
Compare TRNS & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRNS
- KROS
- Stock Information
- Founded
- TRNS 1964
- KROS 2015
- Country
- TRNS United States
- KROS United States
- Employees
- TRNS N/A
- KROS N/A
- Industry
- TRNS Electrical Products
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- TRNS Industrials
- KROS Health Care
- Exchange
- TRNS Nasdaq
- KROS Nasdaq
- Market Cap
- TRNS 661.7M
- KROS 565.0M
- IPO Year
- TRNS N/A
- KROS 2020
- Fundamental
- Price
- TRNS $77.70
- KROS $14.79
- Analyst Decision
- TRNS Buy
- KROS Buy
- Analyst Count
- TRNS 4
- KROS 14
- Target Price
- TRNS $108.67
- KROS $20.56
- AVG Volume (30 Days)
- TRNS 67.2K
- KROS 1.1M
- Earning Date
- TRNS 11-03-2025
- KROS 11-06-2025
- Dividend Yield
- TRNS N/A
- KROS N/A
- EPS Growth
- TRNS N/A
- KROS N/A
- EPS
- TRNS 1.44
- KROS 0.47
- Revenue
- TRNS $288,138,000.00
- KROS $232,844,000.00
- Revenue This Year
- TRNS $18.46
- KROS $6,657.47
- Revenue Next Year
- TRNS $7.49
- KROS N/A
- P/E Ratio
- TRNS $53.31
- KROS $32.30
- Revenue Growth
- TRNS 8.49
- KROS 85820.30
- 52 Week Low
- TRNS $67.56
- KROS $9.12
- 52 Week High
- TRNS $122.08
- KROS $72.37
- Technical
- Relative Strength Index (RSI)
- TRNS 57.83
- KROS 46.08
- Support Level
- TRNS $70.97
- KROS $14.74
- Resistance Level
- TRNS $80.60
- KROS $15.54
- Average True Range (ATR)
- TRNS 2.79
- KROS 0.67
- MACD
- TRNS 1.18
- KROS -0.03
- Stochastic Oscillator
- TRNS 74.11
- KROS 46.65
About TRNS Transcat Inc.
Transcat Inc is involved in providing calibration and laboratory instrument services and the distribution of test, measurement, and control instrumentation. The product and services portfolio of the company consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, and others. The firm has Service and Distribution operating segments. The company derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Extech, FLIR, Fluke, Keysight, Megger, and others.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.